Operator
Welcome to Devyser Diagnostics Q4 Report 2025 Presentation. [Operator Instructions] Now I will hand the conference over to the speakers, CEO, Jan Wahlstrom; CFO, Sabina Berlin; and CCO, Theis Kipling. Please go ahead.
Jan Wahlstrom
Chief Executive Officer
Good day, and welcome to the Devyser Q4 2025 earnings call. I’m Jan Wahlstrom, CEO of Devyser, and I would like to thank you, everyone, for joining our call today. Today’s presenters on the call today, we have, in addition to myself, also our CFO, Sabina Berlin; and our CCO, Theis Kipling.
I will start with a short summary of our quarter result and then recap our recent activities that resulted in a record profitable quarter as well as a record sales quarter. I will give you an update on the recent product launches and present some additional highlights from the quarter before handing over to Sabina for a more detailed review of our financial results in Q4 2025 and then to Theis for an update on our recent commercial activities.
As headlines, I would say that we have started a new journey in the beginning of this year and focused the company towards profitable growth. For the full year, we now deliver EBIT profitability, and we will continue to focus on costs at the same time as we drive to growth at a high pace.
Looking at the fourth quarter highlights, we are turning the company
